Proposed algorithm for early postoperative evaluation after endonasal endoscopic resection of pituitary adenomas with suprasellar extension

针对垂体腺瘤(伴鞍上延伸)经鼻内镜切除术后早期评估,提出了一种算法。

阅读:2

Abstract

BACKGROUND: Pituitary adenomas account for 10-15% of intracranial tumors and are commonly treated with endoscopic transsphenoidal surgery. However, postoperative care protocols and the management of complications, especially in limited-resource settings, remain poorly standardized. This study evaluates the effectiveness of a postoperative monitoring protocol implemented in the intermediate postoperative care unit (IPCU) for early complication detection and management. METHODS: This retrospective case series includes 77 patients who underwent endoscopic pituitary adenoma resection between March 2021 and February 2023. A postoperative monitoring algorithm focused on the early identification and management of complications was implemented in the IPCU. Descriptive and inferential statistical methods were employed to analyze the data. RESULTS: Among the patients, 5.2% developed vasospasm, and 2.6% experienced hydrocephalus. Patients with suprasellar extension had significantly longer IPCU stays compared to those with sellar-only tumors. The modified Rankin scale was found to be significantly associated with the occurrence of postoperative vasospasm. While no significant associations were observed between tumor characteristics and complications, trends were noted regarding clinical outcomes such as total hospital stay and discharge Rankin score. CONCLUSION: The standardized postoperative care protocol in the IPCU effectively identified and managed early complications, including vasospasm, following endoscopic pituitary adenoma surgery. Further research, particularly multicenter studies, is necessary to validate these findings and establish standardized care protocols across healthcare institutions.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。